AstraZeneca Sees Prilosec OTC As “Neutral To Beneficial” For Nexium Sales

The effect Prilosec OTC has on health plan formularies may provide an upshot for sales of AstraZeneca's follow-on Nexium (esomeprazole), CFO Jonathan Symonds said during an Oct. 23 earnings call